Compare · GE vs PBAX
GE vs PBAX
Side-by-side comparison of GE Aerospace (GE) and Phoenix Biotech Acquisition Corp. (PBAX): market cap, price performance, sector, and recent activity on the wire.
Summary
- GE operates in Technology, while PBAX operates in Industrials - the two are in different parts of the market.
- GE is the larger of the two at $342.21B, about 1502.6x PBAX ($227.7M).
- GE has hit the wire 4 times in the past 4 weeks while PBAX has been quiet.
- GE has more recent analyst coverage (25 ratings vs 0 for PBAX).
- Company
- GE Aerospace
- Phoenix Biotech Acquisition Corp.
- Price
- $323.98-1.27%
- $5.45+14.26%
- Market cap
- $342.21B
- $227.7M
- 1M return
- +6.98%
- -
- 1Y return
- +28.76%
- -
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 0
GE Aerospace
General Electric Company operates as a high-tech industrial company worldwide. The company's Power segment offers heavy-duty and aeroderivative gas turbines for utilities, independent power producers, and industrial applications; maintenance, service, and upgrade solutions to plant assets and their operational lifecycle; steam power technology for fossil and nuclear applications, including boilers, generators, steam turbines, and air quality control systems; and advanced reactor technologies solutions comprising reactors, fuels, and support services for boiling water reactors. This segment also applies the science and systems of power conversion to provide motors, generators, automation, and control equipment; and drives for energy intensive industries, such as marine, oil and gas, mining, rail, metals, test systems, and water. Its Renewable Energy segment provides various solutions for its customers through combining onshore and offshore wind, blades, hydro, storage, solar, and grid solutions, as well as hybrid renewables and digital services offerings. The company's Aviation segment designs and produces commercial and military aircraft engines, integrated engine components, electric power, and mechanical aircraft systems; and provides aftermarket services. Its Healthcare segment develops, manufactures, markets, and services magnetic resonance, computed tomography, molecular imaging, x-ray and high-frequency soundwave systems, clinical monitoring and acute care systems, enterprise digital, artificial intelligence applications, consulting and command center, and complementary software and services; and researches, manufactures, and markets imaging agents. The company's Capital segment offers aviation leasing and financing, and working capital services; financial solutions and underwriting capabilities; and insurance and reinsurance for life and health risks, as well as annuity products. The company was founded in 1878 and is headquartered in Boston, Massachusetts.
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Latest GE
- GE Aerospace and Wolfspeed Collaborate to Accelerate High-Voltage Silicon Carbide (SiC) Adoption
- SEC Form SD filed by GE Aerospace
- Seaport Research Partners initiated coverage on GE Aerospace with a new price target
- GE Aerospace Awarded U.S. Air Force Contract to Advance GE426 Engine for Autonomous Collaborative Platform
- Director Mcdew Darren W was granted 678 shares, increasing direct ownership by 32% to 2,830 units (SEC Form 4)
- GE Aerospace filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update
- Director Horton Thomas W was granted 678 shares, increasing direct ownership by 32% to 2,823 units (SEC Form 4)
- Director Goren Isabella D was granted 678 shares, increasing direct ownership by 32% to 2,830 units (SEC Form 4)
- Director Lesjak Catherine A was granted 678 shares, increasing direct ownership by 32% to 2,823 units (SEC Form 4)
- Director Bush Wesley G was granted 678 shares, increasing direct ownership by 258% to 941 units (SEC Form 4)
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)